Status:
COMPLETED
Development of a Marker of Adherence for Tracking Consumption of Nutrient Supplements
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
Bill and Melinda Gates Foundation
Conditions:
Adherence, Treatment
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether selected adherence markers can be used to track daily or intermittent consumption of nutrient supplements.
Detailed Description
The investigators will assess whether urinary concentrations of selected adherence markers can be used to distinguish between daily or intermittent consumption of lipid-based nutrient supplements.
Eligibility Criteria
Inclusion
- non-pregnant, non-lactating women
Exclusion
- BMI \<18.5kg/m2 or \>25.0 kg/m2
- Diagnosis of chronic disease
- Use of medication that can affect gastrointestinal mobility
- Consumption of more than 7 alcoholic drinks per week
- Smoking
- Unwillingness to refrain from consuming dietary sources of the marker compound(s) 3 days prior to, and during the 12 day urine collection period
- Unwillingness to adhere to the study protocol
- Peanut allergy
- Cow milk allergy
- Soy allergy
- Almond allergy
- Allergy to adherence markers
- Pregnancy
Key Trial Info
Start Date :
July 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04040543
Start Date
July 26 2019
End Date
November 30 2020
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis
Davis, California, United States, 95616